Cita APA

Dupé, V., Matt, N., Garnier, J., Chambon, P., Mark, M., & Ghyselinck, N. B. (2003). A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. National Academy of Sciences.

Citación estilo Chicago

Dupé, Valérie, Nicolas Matt, Jean-Marie Garnier, Pierre Chambon, Manuel Mark, y Norbert B. Ghyselinck. A Newborn Lethal Defect Due to Inactivation of Retinaldehyde Dehydrogenase Type 3 Is Prevented By Maternal Retinoic Acid Treatment. National Academy of Sciences, 2003.

Cita MLA

Dupé, Valérie, et al. A Newborn Lethal Defect Due to Inactivation of Retinaldehyde Dehydrogenase Type 3 Is Prevented By Maternal Retinoic Acid Treatment. National Academy of Sciences, 2003.